LabVantage Launches Full-Featured Self-Service Advanced Analytics Solution

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced the launch of LabVantage Analytics, a full-featured, self-service advanced analytics solution that lets users easily explore, analyze, and visualize LIMS, enterprise, and external data to gain actionable business insights. Designed by analytics industry experts, LabVantage Analytics seamlessly integrates with all elements of the LabVantage LIMS platform, providing a single user interface and workflow.

LabVantage Solutions Names Digital Transformation Leader Mikael Hagstroem as CEO

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, has appointed Mikael Hagstroem as Chief Executive Officer.

LabVantage Emphasizes Cybersecurity with Version 8.6 of Its LIMS Platform

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced that the 8.6 edition of its flagship LIMS has been designed and tested to optimum cybersecurity standards.

LabVantage Adds Vendor Validation to Its Software-as-a-Service LIMS

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced it has added validation to a number of its subscription-based LIMS. Adding validation support to a cloud-hosted, Software-as-a-Service (SaaS) LIMS increases confidence for organizations that function in regulated sectors, such as pharmaceuticals, biobanking, and clinical and molecular diagnostics.

New Healthcare Industry Survey Reveals Majority of Healthcare Organizations Unprepared for ONC Cures Act Final Rule

MedAI Integrates Its Drug Research and Development Platform for the Pharmaceutical Industry

Earlier this month, MedAI announces to have integrated its drug research and development platform for the pharmaceutical industry. The company is specialized in AI-assisted R&D and it now provides a wide range of solutions that covers nearly every stage of early drug development, including developing drug targets, biomarker discovery, chemical drug development, protein/antibody development, prediction of drug, crystal form, ADMET prediction, repurposing existing drugs, drug formulation development.

Kiniciti Welcomes Two Cell and Gene Therapy Industry Leaders to its Advisory Board

Kiniciti, a Welsh, Carson, Anderson & Stowe (“WCAS”) platform company that invests in non-therapeutic companies supporting Cell and Gene Therapy innovation, announced the formation of an Advisory Board and appointment of two inaugural members: Denis Bedoret, PhD, chief executive officer of Imcyse, and Andrew Knudten, chief operating officer of Jaguar Gene Therapy.

Cresset expands its Board with the appointment of David Newble as Non-Executive Director

Seven Bridges Launches the GRAF™ Population Solution — Population-Specific Tools and Services to Enhance Genetic Variation Discovery

Bioinformatics methods suffer from a significant loss of accuracy when used on sequencing data from under-represented populations because the genetic information of such populations cannot be captured in the linear reference genome. The inherent bias in the industry’s current reference genome favors the European population. A pan-genome approach can provide significant improvements, but it is still suboptimal. The Seven Bridges GRAF Population Solution is ancestry-aware and, therefore, more accurate than both linear and pan-genome approaches.

Qlucore announces major new release (3.7) with ChIP-seq and Biomarker support

Qlucore, leading software provider of powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics, announces Qlucore Omics Explorer (QOE) version 3.7, an extensive upgrade adding features in many different areas to strengthen visual analysis support even further.

Creative BioMart Biomarker Released Multiple Biomarker Detection Service

Formulationbio Newly Launches Disintegrant Excipients for Pharmaceutical Preparation

Insightful Science Joins Forces with Dotmatics to Form a Leading Cloud-First Scientific R&D Company

Continuous manufacturing μLOT® enabling technology could cut pharma industry’s use of toxic chemicals by one hundred times

Continuous manufacturing μLOT® enabling technology could cut pharma industry’s use of toxic chemicals by one hundred times.

Baltimore Aircoil Company Highlights ENDURADRIVE® Fan System for Ideal Cooling in Mission-Critical Environments

ENDURADRIVE® Fan System provides peace of mind and unmatched reliability, thanks to its advanced design

Matexcel Offers a Comprehensive List of Graphene Products

Tech and IoMT R&D Firm Commit Expands to North America Under Leadership of CRO and Managing Director, Max Nirenberg

Commit, the leading Israeli-based global tech and custom software solutions firm is expanding into North America.

Creative Biostructure Provides Various Vaccine Development Services for Coronavirus

CD BioSciences is Ready to Provide Clinical Data Management Service

CD BioSciences, a US based supplier of one-stop clinical trial services, has announced to provide global scientists with clinical data management, analysis and reporting service.

THREAD and Lokavant Partner to Provide Sponsors with First DCT Benchmarking Solution

THREAD and Lokavant partner